Anixa Biosciences, Inc.
ANIX

$100.4 M
Marketcap
$3.12
Share price
Country
$0.02
Change (1 day)
$5.13
Year High
$2.15
Year Low
Categories

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

marketcap

Revenue of Anixa Biosciences, Inc. (ANIX)

Revenue in 2023 (TTM): $210 K

According to Anixa Biosciences, Inc.'s latest financial reports the company's current revenue (TTM) is $210 K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Anixa Biosciences, Inc.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $210 K $49 K $-10,965,000 $-9,930,000 $-9,811,000
2022 $2.47 B $2.47 B $-13,729,000 $-13,771,000 $-13,491,000
2021 $512.5 K $127.5 K $-13,081,275 $-13,127,923 $-12,946,631
2020 $ $-90,157 $-10,002,202 $-10,092,363 $-10,132,516
2019 $250 K $83.75 K $-11,004,947 $-11,818,652 $-11,994,451
2018 $1.11 M $344.09 K $-13,362,348 $-14,243,084 $-13,996,025
2017 $362.5 K $257.94 K $-4,140,024 $-5,008,991 $-5,008,991
2016 $300 K $82.58 K $-4,137,853 $-5,016,428 $-5,016,428
2015 $9.26 M $5.61 M $-601,846 $-1,379,043 $-1,379,043
2014 $3.67 M $1.68 M $-8,028,242 $-9,606,314 $-9,606,314
2013 $388.85 K $72.19 K $-8,970,567 $-10,080,086 $-10,080,086
2012 $940.01 K $936.14 K $-4,237,904 $-4,252,799 $-4,252,799
2011 $1 M $969.11 K $-6,770,056 $-6,778,036 $-7,378,036
2010 $730.68 K $648.37 K $-5,248,220 $-5,175,131 $-5,175,131
2009 $1.06 M $990.11 K $-7,320,318 $-16,489,015 $-16,489,015
2008 $2.06 M $1.97 M $-5,978,849 $-5,821,604 $-5,821,604
2007 $486.85 K $326.49 K $-5,448,329 $ $-5,458,218
2006 $508.65 K $352.21 K $-7,612,544 $ $-7,600,901
2005 $439.79 K $-279,843 $-4,451,058 $ $-4,451,257
2004 $494.46 K $318.35 K $-3,347,991 $ $-3,360,655
2003 $244.22 K $68.28 K $-3,085,996 $ $-3,114,411
2002 $5.19 M $3.32 M $-3,222,275 $-6,129,546 $-3,285,240
2001 $1.69 M $993.13 K $-3,437,733 $ $-3,571,957
2000 $1.47 M $1.01 M $-4,823,348 $ $-4,964,173
1999 $100 K $400 K $-7,900,000 $-8,500,000 $-8,500,000
1998 $100 K $400 K $-6,800,000 $-7,000,000 $-7,100,000
1997 $100 K $400 K $-6,000,000 $-5,700,000 $-5,800,000
1996 $100 K $200 K $-5,900,000 $-5,400,000 $-5,400,000
1995 $100 K $200 K $-3,200,000 $-2,900,000 $-3,000,000
1994 $100 K $200 K $-3,500,000 $-3,400,000 $-3,400,000
1993 $100 K $100 K $-3,000,000 $-2,600,000 $-2,800,000
1992 $100 K $100 K $-2,100,000 $-1,700,000 $-1,800,000
1991 $100 K $100 K $-1,600,000 $-1,200,000 $-1,300,000
1990 $100 K $100 K $-1,300,000 $-1,100,000 $-1,100,000
1989 $100 K $100 K $-1,100,000 $-1,000,000 $-1,100,000
1988 $100 K $100 K $-1,200,000 $-1,200,000 $-1,300,000
1987 $100 K $100 K $-1,200,000 $ $-1,400,000
1986 $100 K $100 K $-1,800,000 $ $-1,800,000
1985 $300 K $300 K $-1,700,000 $ $-1,700,000